Aurobindo Pharma subsidiary’s plant gets one observation from USFDA August 29, 2022 AutoBot News 0 “At the end of the inspection, Aurolife has been issued a ‘Form 483’ with 1 observation and the observation is procedural in nature and there are no data integrity issues,” Aurobindo Pharma said.